This page lists all pharmaceutical reports related to the field of Oncology. The reports include market research reports and pipeline analyses.
Displaying 151 - 200 of 203 results
- Biotech M&A and Licensing Strategies - Co-development Agreements are Poised to Increase in the Future to Counter Drying Pipelines
- Clinical Trial Recruitment Strategies in Oncology - Online Recruitment Methods and Use of IT - enabled Patient Management Systems will Reduce Recruitment Time and Cost
- Cancer Supportive Care Products Market to 2016 - Market is Expected to Decline after 2014 Due to Generic Erosion and Entry of Biosimilars
- Top R&D Drug Failures - Toxicity and Serious Adverse Events in Late Stage Drug Development are the Major Causes of Drug Failure
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Clinical Trial Endpoints in Oncology - Inclusion of Surrogate Endpoints and Shorter Endpoints Will Ensure Faster Clinical Trials in Oncology
- Comparative Analysis of Late Stage Pipeline Molecules in Major Indications - Oncology Pipeline Leads with Most Promising Molecules in Late Stage Development
- Vaginal Cancer - Pipeline Review, H2 2011
- AIDS - Related Cancers - Pipeline Review, H2 2011
- Vulvar Cancer - Pipeline Review, H2 2011
- Lung Cancer Vaccines and Therapeutic Antibodies: Pipeline, Strategies and Clinical
- Plasma Cell Neoplasm - Pipeline Review, H2 2011
- Hypopharyngeal Cancer - Pipeline Review, H2 2011
- Squamous Cell Carcinoma - Pipeline Review, H2 2011
- Osteosarcoma - Pipeline Review, H2 2011
- Pediatric Cancer - Pipeline Review, H2 2011
- Thymus Cancer - Pipeline Review, H2 2011
- Lip And Oral Cavity Cancer - Pipeline Review, H2 2011
- Carcinoma Of The Bile Duct - Pipeline Review, H2 2011
- Metastatic Brain Tumors - Pipeline Review, H2 2011
- Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market
- Preclinical Models - Preclinical CROs will Continue to Improve the Quality and Accuracy of Data for Targeted Therapies
- Biomarkers in Drug Discovery - Earlier Usage of Biomarkers in Optimization Stage to Reduce Drug Attrition Rate Significantly
- Miripla (Liver Cancer) – Analysis and Forecasts to 2020
- Gleevec (Pulmonary Arterial Hypertension) - Analysis and Forecasts to 2020
- ThermoDox (Liver Cancer) – Analysis and Forecasts to 2020
- Doxorubicin (Liver Cancer) – Analysis and Forecasts to 2020
- Thalidomide (Liver Cancer) – Analysis and Forecasts to 2020
- Muparfostat (Liver Cancer) – Analysis and Forecasts to 2020
- PrevOnco (Liver Cancer) – Analysis and Forecasts to 2020
- Nexavar (Liver Cancer) – Analysis and Forecasts to 2020
- Avastin (Liver Cancer) – Analysis and Forecasts to 2020
- Emerging Cancer Vaccines Market to 2017 - Novel, First-In-Class Vaccines in Phase II and Phase III Pipeline to Shape the Future Cancer Vaccines Market
- GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
- Tarceva (Liver Cancer) – Analysis and Forecasts to 2020
- Ramucirumab (Liver Cancer) – Analysis and Forecasts to 2020
- Linifanib (Liver Cancer) – Assessment and Forecasts to 2020
- Brivanib (Liver Cancer) – Analysis and Forecasts to 2020
- Neuroendocrine Carcinoma Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Oral Mucositis Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Esophageal Cancer Therapeutics - Pipeline Assessment and Market Forecast to 2017
- Hodgkin Lymphoma (HL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Acute Lymphocytic Leukemia (ALL) Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Small Cell Lung Cancer (SCLC) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Malignant Mesothelioma Therapeutics - Pipeline Assessment and Market Forecasts to 2017
- Clinical Trial Recruitment in Orphan Diseases - Patient Numbers in Ovarian Cancer Trials Exceed Other Orphan Diseases in Oncology
- Multiple Myeloma Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Non-Hodgkin's Lymphoma (NHL) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Glioblastoma Multiforme (GBM) Therapeutics - Pipeline Assessment and Market Forecasts to 2018
- Ovarian Cancer Therapeutics - Pipeline Assessment and Market Forecasts to 2017